Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewVa Capital Partners is a venture capital and private equity firm based in Blacksburg, Virginia, primarily focused on early-stage and growth-stage investments within the 'NewVa' region of Southwest Virginia. Founded in 2004, the firm was established to bridge the funding gap for innovative startups emerging from regional research institutions, particularly Virginia Tech. NewVa Capital Partners targets companies in the life sciences, biotechnology, and information technology sectors, providing both financial backing and strategic guidance. The firm played a significant role in the development of the regional technology corridor, with notable early investments in companies like Intrexon (now Precigen). While the fund is no longer actively making new investments, it remains a key part of the history of the Virginia biotechnology ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewVa Capital Partners.